• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无定形阿奇霉素的溶液介导结晶。

Solution-mediated crystallization of amorphous azithromycin.

作者信息

Stieger N, Joubert A, Liebenberg W

出版信息

Pharmazie. 2017 Aug 1;72(8):447-448. doi: 10.1691/ph.2017.7035.

DOI:10.1691/ph.2017.7035
PMID:29441902
Abstract

Water and water vapor are the bane of amorphous drug stability, both in storage and after administration. As is to be expected, crystallization of amorphous azithromycin did occur when exposed to water as dissolution medium. However, experimental results showed that, although solution-mediated phase transformation had occurred, it was not a rapid process for this drug. It is considered to be an advantageous characteristic of amorphous azithromycin and likely due to the high molecular mass (748.984 g/mol) and complex structure necessitating more energy for transformations to occur. A high apparent solubility is maintained for a considerable period of time, potentially rendering a higher percentage of this BCS Class II drug available for absorption when administered orally.

摘要

无论是在储存过程中还是给药后,水和水蒸气都是无定形药物稳定性的克星。不出所料,当以水作为溶解介质时,无定形阿奇霉素确实发生了结晶。然而,实验结果表明,尽管发生了溶液介导的相变,但对这种药物来说这并不是一个快速的过程。这被认为是无定形阿奇霉素的一个有利特性,可能是由于其高分子量(748.984 g/mol)和复杂的结构,使得转变需要更多能量。在相当长的一段时间内保持较高的表观溶解度,这可能使这种BCS II类药物在口服给药时可供吸收的百分比更高。

相似文献

1
Solution-mediated crystallization of amorphous azithromycin.无定形阿奇霉素的溶液介导结晶。
Pharmazie. 2017 Aug 1;72(8):447-448. doi: 10.1691/ph.2017.7035.
2
Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability.具有改善的水溶性和肠膜通透性的无定形阿奇霉素。
Drug Dev Ind Pharm. 2015;41(7):1100-8. doi: 10.3109/03639045.2014.931967. Epub 2014 Jul 1.
3
Preparation of azithromycin nanosuspensions by reactive precipitation method.采用反应沉淀法制备阿奇霉素纳米混悬液。
Drug Dev Ind Pharm. 2012 Jul;38(7):848-54. doi: 10.3109/03639045.2011.630394. Epub 2011 Nov 17.
4
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
5
Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions.药物无定形固体分散体的溶解性优势(及劣势)
J Pharm Sci. 2016 Dec;105(12):3549-3561. doi: 10.1016/j.xphs.2016.08.017. Epub 2016 Sep 28.
6
Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.由2,6-二-O-甲基-β-环糊精水溶液制备无定形吲哚美辛
Int J Pharm. 2008 Apr 16;354(1-2):70-6. doi: 10.1016/j.ijpharm.2007.11.010. Epub 2007 Nov 17.
7
Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.利用液-液相分离现象增强难溶性药物的膜转运并实现持续释放
Mol Pharm. 2016 Jun 6;13(6):2059-69. doi: 10.1021/acs.molpharmaceut.6b00202. Epub 2016 May 11.
8
Maximum Loaded Amorphous Azithromycin Produced Using the Wetness Impregnation Method with Fractional Steps for Dermal Prophylaxis Against Lyme Disease.采用分步湿浸法制备的用于皮肤预防莱姆病的最大负载量无定形阿奇霉素。
Pharmazie. 2019 Jun 1;74(6):345-349. doi: 10.1691/ph.2019.8175.
9
Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.无定形吲哚美辛在溶解过程中的结晶:加工和退火的影响。
Mol Pharm. 2010 Oct 4;7(5):1406-18. doi: 10.1021/mp1000197. Epub 2010 May 20.
10
Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.水溶解度的晶体和无定形药物:测量的挑战。
Pharm Dev Technol. 2011 Jun;16(3):187-200. doi: 10.3109/10837451003774377. Epub 2010 Apr 30.